Thyrocare Technologies Reports Q4 Results, Dividend And CEO Reappointment

Thyrocare Technologies Ltd, a leading diagnostic services provider, announced its March quarter results along with key corporate updates. The company’s performance reflects resilience in the healthcare sector, supported by steady demand for diagnostic services and efficient operations.

Financial Performance

Revenue from operations stood at ₹2.24 billion, while net profit reached ₹471.2 million. The results highlight Thyrocare’s ability to maintain profitability despite competitive pressures in the diagnostics industry.

Dividend Declaration

The board approved a dividend of ₹7 per share, underscoring confidence in the company’s cash flow and commitment to shareholder value creation.

Leadership Continuity

Rahul Franklin Guha’s reappointment as MD & CEO ensures strategic stability. His leadership is expected to drive innovation, strengthen market presence, and enhance service delivery in the growing diagnostics sector.

Key highlights

• Consolidated revenue at ₹2.24 billion in Q4
• Net profit reported at ₹471.2 million
• Dividend declared at ₹7 per share
• Board reappoints Rahul Franklin Guha as MD & CEO
• Focus on shareholder returns and leadership stability

Sources: Company filings, Reuters updates, market reports